FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4327748152> ?p ?o ?g. }

• W4327748152 endingPage "414.e5" @default.
• W4327748152 startingPage "403" @default.
• W4327748152 abstract "Primary urinary neuroendocrine neoplasms (U-NENs) are extremely rare thus optimal treatment is unknown. Grading and treatment are typically extrapolated from other primary sites. Since 2010, the clinical landscape for NENs has changed substantially. We performed a retrospective review of U-NENs to assess treatment patterns and oncologic outcomes of patients treated in the recent era of NEN therapy.A multicenter retrospective review of patients diagnosed after 2005 and alive after 2010. Time to treatment failure (TTF) was used to evaluate progression and toxicity for systemic therapy. Tumors were categorized as having either well-differentiated neuroendocrine tumor (WDNET) or poorly differentiated neuroendocrine carcinoma (PDNEC) histology.A total of 134 patients from 6 centers were included in our analysis, including 94 (70%) bladder, 32 (24%) kidney, 2 (1.5%) urethra and 4 other urinary primaries (3.0%). Poorly-differentiated neuroendocrine carcinoma was more common in bladder (92%) than non-bladder tumors (8%). Median Ki-67 available in bladder primary was 90% (n = 24), kidney 10% (n = 23), ureter 95% (n = 1), urethra 54% (n = 2), and others 90% (n = 3). Patients received a median of 2 therapies (range 0-10). Median time to death was not reached in locoregional WDNETs versus 8.2 years (95% CI, 3.5-noncalculable) in metastatic WDNETs (predominantly renal primary). Median time to death was 3.6 years (95% CI, 2.2-9.2) in locoregional PDNECs versus 1 year (95% CI, 0.8-1.3) in metastatic PDNECs (predominantly bladder primary).This is the most extensive series examining treatment patterns in patients with U-NENs in the recent era of NEN therapy. The apparent inferior survival for bladder NENs is likely due to the preponderance of PDNECs in this group. As predicted, treatments for U-NENs mirrored that of other more common NENs. In our retrospective cohort, we observed that patients with WD-UNETs treated with peptide receptor radionuclide therapy (PRRT) and everolimus suggested potential activity for disease control in WD-UNETs. Prospective studies are needed to assess the activity of new oncology drugs in UNENs." @default.
• W4327748152 created "2023-03-18" @default.
• W4327748152 creator A5015057673 @default.
• W4327748152 creator A5032598163 @default.
• W4327748152 creator A5033960518 @default.
• W4327748152 creator A5035188335 @default.
• W4327748152 creator A5036010292 @default.
• W4327748152 creator A5037936050 @default.
• W4327748152 creator A5039083730 @default.
• W4327748152 creator A5045128575 @default.
• W4327748152 creator A5055085301 @default.
• W4327748152 creator A5059768717 @default.
• W4327748152 creator A5068020924 @default.
• W4327748152 creator A5073793833 @default.
• W4327748152 creator A5074184830 @default.
• W4327748152 creator A5080763042 @default.
• W4327748152 creator A5090608376 @default.
• W4327748152 creator A5037532225 @default.
• W4327748152 date "2023-06-01" @default.
• W4327748152 modified "2023-10-16" @default.
• W4327748152 title "Urinary Neuroendocrine Neoplasms Treated in the “Modern Era”: A Multicenter Retrospective Review" @default.
• W4327748152 cites W1531223663 @default.
• W4327748152 cites W1870858767 @default.
• W4327748152 cites W1995681258 @default.
• W4327748152 cites W2001259580 @default.
• W4327748152 cites W2005319600 @default.
• W4327748152 cites W2008618741 @default.
• W4327748152 cites W2039189909 @default.
• W4327748152 cites W2039511031 @default.
• W4327748152 cites W2071851324 @default.
• W4327748152 cites W2079144528 @default.
• W4327748152 cites W2094551615 @default.
• W4327748152 cites W2099144023 @default.
• W4327748152 cites W2106315111 @default.
• W4327748152 cites W2135049144 @default.
• W4327748152 cites W2149214723 @default.
• W4327748152 cites W2161676563 @default.
• W4327748152 cites W2232569012 @default.
• W4327748152 cites W2237254160 @default.
• W4327748152 cites W2284518822 @default.
• W4327748152 cites W2415950182 @default.
• W4327748152 cites W2464361728 @default.
• W4327748152 cites W2558408743 @default.
• W4327748152 cites W2560376111 @default.
• W4327748152 cites W2573369749 @default.
• W4327748152 cites W2603879439 @default.
• W4327748152 cites W2605007480 @default.
• W4327748152 cites W2608160487 @default.
• W4327748152 cites W2612230723 @default.
• W4327748152 cites W2737911811 @default.
• W4327748152 cites W2775732618 @default.
• W4327748152 cites W2805072632 @default.
• W4327748152 cites W2893960509 @default.
• W4327748152 cites W2898200463 @default.
• W4327748152 cites W2912485050 @default.
• W4327748152 cites W2947840610 @default.
• W4327748152 cites W2952852659 @default.
• W4327748152 cites W2969542839 @default.
• W4327748152 cites W2977392388 @default.
• W4327748152 cites W2993066273 @default.
• W4327748152 cites W3002973089 @default.
• W4327748152 cites W3009875356 @default.
• W4327748152 cites W3015529215 @default.
• W4327748152 cites W3034229498 @default.
• W4327748152 cites W3035208766 @default.
• W4327748152 cites W3087238097 @default.
• W4327748152 cites W3104415093 @default.
• W4327748152 cites W3122740654 @default.
• W4327748152 cites W3126018719 @default.
• W4327748152 cites W3155380067 @default.
• W4327748152 cites W3155998054 @default.
• W4327748152 cites W3157076486 @default.
• W4327748152 cites W3157209351 @default.
• W4327748152 cites W3165012737 @default.
• W4327748152 cites W3190487880 @default.
• W4327748152 cites W4206038052 @default.
• W4327748152 cites W4206135283 @default.
• W4327748152 cites W4221079021 @default.
• W4327748152 cites W4225291722 @default.
• W4327748152 cites W4235705773 @default.
• W4327748152 cites W4280507164 @default.
• W4327748152 doi "https://doi.org/10.1016/j.clgc.2023.02.009" @default.
• W4327748152 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37031047" @default.
• W4327748152 hasPublicationYear "2023" @default.
• W4327748152 type Work @default.
• W4327748152 citedByCount "0" @default.
• W4327748152 crossrefType "journal-article" @default.
• W4327748152 hasAuthorship W4327748152A5015057673 @default.
• W4327748152 hasAuthorship W4327748152A5032598163 @default.
• W4327748152 hasAuthorship W4327748152A5033960518 @default.
• W4327748152 hasAuthorship W4327748152A5035188335 @default.
• W4327748152 hasAuthorship W4327748152A5036010292 @default.
• W4327748152 hasAuthorship W4327748152A5037532225 @default.
• W4327748152 hasAuthorship W4327748152A5037936050 @default.
• W4327748152 hasAuthorship W4327748152A5039083730 @default.
• W4327748152 hasAuthorship W4327748152A5045128575 @default.
• W4327748152 hasAuthorship W4327748152A5055085301 @default.
• W4327748152 hasAuthorship W4327748152A5059768717 @default.

• next